top of page

REGAIN Trial (Spinal Anaesthesia or General Anaesthesia for Hip Surgery in Older Adults

Journal N Engl J Med 2021; 385:2025-2035

DOI: 10.1056/MEJMoa2113514

What's the question?

  • In previously ambulatory adults aged >50 years undergoing surgery for hip fracture, does spinal anaesthesia, compared with general anaesthesia, increase the likelihood of being alive and able to walk independently at 60 days?

Background Information

  • Nearly all patients with hip fracture undergo surgery, most commonly under spinal or general anaesthesia.

  • Observational studies suggested spinal anaesthesia was associated with lower rates of death, delirium and major medical complications, and shorter hospital stays.

  • Previous randomised trials gave conflicting results; most were over 30 years old, small, and not designed to assess outcomes beyond hospital discharge.

  • Recovery of independent walking is a patient priority but had not been studied. US use of spinal anaesthesia for hip-fracture surgery rose by 50% between 2007 and 2017, possibly reflecting a belief in its superiority.

The study

  • REGAIN: a pragmatic, multicentre, randomised superiority trial at 46 US and Canadian hospitals (February 2016 to February 2021), designed with patient and stakeholder input.

  • 1,600 patients (mean age 78 years; 67% women) randomised 1:1 to spinal (n=795) or general (n=805) anaesthesia, stratified by hospital, sex and fracture location. Patients and clinicians were unblinded; 60-day outcome assessors were blinded.

  • Spinal group: single-injection spinal with sedation titrated to an OAAS score of 2–5. General group: inhaled maintenance agent with airway management per local practice. Exclusions included contraindications to spinal anaesthesia (coagulopathy, anticoagulant or antiplatelet use, severe aortic stenosis).

  • Primary outcome (death or inability to walk ~10 ft [3 m] independently or with a walker or cane at 60 days): spinal 18.5% vs general 18.0% (relative risk [RR] 1.03, 95% CI 0.84–1.27; P=0.83).

  • Secondary outcomes were similar: death at 60 days 3.9% vs 4.1% (RR 0.97); new inability to walk among survivors 15.2% vs 14.4% (RR 1.05); new-onset delirium 20.5% vs 19.7% (RR 1.04); time to discharge similar.

  • Exploratory outcomes (low event rates, unadjusted for multiplicity): in-hospital death 0.6% vs 1.6%, acute kidney injury 4.5% vs 7.6%, and critical care admission 2.3% vs 3.7%, all lower with spinal anaesthesia.

  • 15.0% of the spinal group received general anaesthesia (mostly failed block placement); 3.5% of the general group received spinal anaesthesia.

Strengths and Weaknesses

  • Strengths: Large, pragmatic trial across academic and community hospitals; patient-centred primary outcome; blinded outcome assessment; death included in the composite to avoid survivorship bias; findings robust in inverse-probability-weighted and instrumental variable (per-protocol) sensitivity analyses; Black patients represented at ~8%, above their share of the US hip-fracture population.

  • Weaknesses: Primary outcome data missing for ~10% of patients; primary event rate (18%) much lower than the 34.2% assumed, reducing power, likely because enrolled patients were healthier than expected; 15% crossover from spinal to general; heterogeneous sedation practice (14% sedated more deeply than the target); clinicians unblinded; only ~7% of screened patients randomised, and anticoagulated patients excluded, limiting generalisability; North America only.

PHRACC's Conclusions

  • Spinal anaesthesia was not superior to general anaesthesia for death or new inability to walk independently at 60 days after hip-fracture surgery in older adults.

  • Rates of postoperative delirium, 60-day mortality and length of stay were similar with the two techniques.

  • Choice of anaesthetic technique for hip-fracture surgery can reasonably be guided by patient preference rather than anticipated differences in clinical outcome.

This page is part of the PHRACC AI-assisted education series. AI has been used to help synthesise information from carefully hand-picked peer-reviewed recent publications which relate to the delivery of healthcare in both the United Kingdom and Australia. Content has been reviewed and edited by the author to minimise the risk of error and incorrect information. PHRACC.com and the author(s) can not be held responsible or liable in any way for any errors in this article and resulting sequelae. The responsibility rests solely with the reader to confirm the accuracy of all information contained here with independent reputable sources before using it for any purpose.

Last updated 29/10/26 by JH

bottom of page